MSTR vs AMPL Stock Comparison

Strategy and Amplitude Prices as of Oct 23, 2026 Peers: Industry group
MSTR Strategy Inc
$146.01 -10.0% 1M -48.8% 1Y
Market cap
$49.33B
P/E
–
Revenue (TTM)
$498.35M
Div. yield
–
Analytics and BI Technology
2 wins
AMPL Amplitude, Inc.
$17.42 +26.6% 1M +74.5% 1Y
Market cap
$2.24B
P/E
–
Revenue (TTM)
$374.37M
Div. yield
–
Analytics and BI Technology
5 wins

Head to Head

7 decided of 12

Amplitude leads on 5 of the 12 questions below (Amplitude 5, Strategy 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMSTRAMPLLeader
Larger companyMarket capitalisation $49.33B $2.24B MSTR
Cheaper on earningsLower P/E, profitable companies only -1.6x -22.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 248.9x –
Faster revenue growthRevenue growth, trailing twelve months +7.8% +18.3% AMPL
More profitableNet margin, trailing twelve months -6,294.3% -26.6% AMPL
Better return on capitalReturn on invested capital -73.9% — –
Less leveragedLower net debt / EBITDA -0.1x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -48.8% +74.5% AMPL
Better 5-year returnAnnualised price return, 5 years +15.2%/yr -23.7%/yr MSTR
Less volatileAnnualised volatility, 1 year 81.1% 65.8% AMPL
Higher overall scoreMean of the five percentile scores vs peers 21/100 40/100 AMPL

Percentile Scorecard

MSTRAMPL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMSTRAMPL
Valuation 8 #93 of 101 15 #86 of 101
Growth 7 #90 of 97 60 #39 of 97
Profitability 8 #87 of 94 29 #67 of 94
Financial Health 80 #23 of 109 58 #46 of 109
Shareholder Returns 3 #62 of 64 40 #39 of 64
Overall 21 40
  • MSTR ranked among 114 companies in Business Applications
  • AMPL ranked among 114 companies in Business Applications

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMSTRAMPLSPY
1 month -10.0%+26.6% -1.0%
3 months +59.3%+115.1% +2.9%
6 months -14.6%+146.7% +6.4%
Year to date -3.9%+50.4% +11.4%
1 year -48.8%+74.5% +13.1%
3 years +243.6%+66.2% +79.4%
3 years, per year +50.9%+18.5% +21.5%
5 years +103.2%-74.2% +67.7%
5 years, per year +15.2%-23.7% +10.9%
10 years +766.0%— +255.2%
10 years, per year +24.1%— +13.5%

Risk

MeasureMSTRAMPLSPY
Volatility, 1Y 81.1%65.8% 12.7%
Downside volatility, 1Y 74.6%64.9% 12.7%
Beta vs S&P 500, 1Y 3.161.08 1.00
Return / volatility, 1Y -0.601.13 1.03
Max drawdown, 5Y -84.1%-93.4% -25.4%
From 52-week high -50.6%0.0% -2.5%
52-week high $295.63$17.42 $779.14
52-week low $82.31$5.61 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMSTRAMPL
P/E now vs peer median -1.6xmedian 29.9x -22.6xmedian 29.9x
P/S now vs peer median 103.1xmedian 2.8x 11.6xmedian 2.8x
EV/EBITDA now vs peer median -1.5xmedian 17.4x -45.2xmedian 17.4x
P/FCF now vs peer median -1,962xmedian 16.9x 147.7xmedian 16.9x
P/B now vs peer median 1.7xmedian 3.1x 31.9xmedian 3.1x
PEG now vs peer median 0.01median 0.86 -5.83median 0.86

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMSTRAMPL
Revenue $498.35M $374.37M
Gross profit $336.89M $271.11M
Operating income -$36.36B -$104.03M
Net income -$30.41B -$99.53M
Free cash flow -$26.19M $29.44M
R&D $93.13M $108.93M
EPS (diluted) $-88.98 $-0.77
Cash & equivalents $1.71B $73.78M
Total debt $6.71B –
Shares (diluted) 352.53M 129.38M
Enterprise value $42.32B $1.54B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMSTRAMPL
P/E -1.6x -22.6x
P/FCF -1,962x 147.7x
P/Operating cash flow -2,558x 136.9x
P/S 103.1x 11.6x
P/B 1.7x 31.9x
P/Tangible book -2.7x 36.0x
EV/EBITDA -1.5x -45.2x
EV/EBIT -1.5x -40.5x
EV/Revenue 111.7x 11.2x
EV/FCF -2,125x 142.9x
EV/Operating cash flow -2,770x 132.5x
PEG (3Y EPS CAGR) 0.01 -5.83

Growth

14 metrics
MetricMSTRAMPL
Revenue growth (1Y) 7.8% 18.3%
Revenue CAGR (3Y) -0.1% 12.8%
Gross profit growth (1Y) 4.0% 15.4%
Gross profit CAGR (3Y) -5.0% 13.1%
Operating income growth (1Y) -645.8% 2.6%
Operating income CAGR (3Y) -437.1% 1.9%
Net income growth (1Y) -734.6% -3.3%
Net income CAGR (3Y) -430.3% 0.4%
EPS growth (1Y) -676.7% -4.9%
EPS CAGR (3Y) -314.6% 3.9%
Operating cash flow growth (1Y) 79.0% 48.7%
Operating cash flow CAGR (3Y) -202.3% 61.0%
Free cash flow growth (1Y) 74.1% 50.1%
Free cash flow CAGR (3Y) -109.9% 74.9%

Profitability

14 metrics
MetricMSTRAMPL
Gross margin 67.6% 72.4%
EBITDA margin -7,284% -24.8%
Operating margin -7,295% -27.8%
Pretax margin -7,280% -25.5%
Net margin -6,294% -26.6%
FCF margin -5.3% 7.9%
Operating cash flow margin -4.0% 8.5%
Return on equity -90.1% -56.3%
Return on assets -56.9% -26.3%
Return on invested capital -73.9% –
Return on capital employed -68.7% -61.7%
Asset turnover 0.0x 1.0x
Cash conversion (OCF / net income) 0.0x -0.3x
Stock comp / revenue 10.7% 25.1%

Financial Health

11 metrics
MetricMSTRAMPL
Debt / assets 12.8% –
Debt / equity 0.2x –
Net debt / EBITDA -0.1x –
Debt / FCF -256.2x –
Liabilities / assets 41.2% 61.8%
Equity / assets 58.8% 38.2%
Interest coverage – –
Current ratio 5.4x 1.0x
Quick ratio 5.2x 0.8x
Cash ratio 4.9x 0.7x
Altman Z-score -1.21 9.59

Shareholder Returns

7 metrics
MetricMSTRAMPL
Dividend yield – –
Net buyback yield -51.6% 2.6%
Shareholder yield -51.6% 2.6%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMSTRAMPL
Forward P/E – 248.9xFY2026
EPS, next fiscal year $-20.12FY2026 $0.07FY2026
EPS growth, next FY – +16.7%FY2026
EPS growth, the year after – +157.1%
Revenue, next fiscal year $466.60MFY2026 $430.21MFY2026
Revenue growth, next FY -2.2%FY2026 +25.3%FY2026
Revenue growth, the year after +14.0% +15.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMSTRAMPL
Held by institutions 57.9% 62.1%
Institutions holding 867 201
Change in shares held, QoQ +12.5% -3.6%
Institutions buying 501 115
Institutions selling 256 62
Buyers to sellers 1.96 1.85

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MSTRAMPL
MSTR 1.00 0.24
AMPL 0.24 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MSTR and AMPL?

Strategy (MSTR) is the largest by market capitalisation: Strategy (MSTR) $49.33B, Amplitude (AMPL) $2.24B.

Which company is growing faster?

Amplitude (AMPL) grew revenue fastest over the trailing twelve months: Strategy (MSTR) +7.8%, Amplitude (AMPL) +18.3%.

Which company is more profitable?

Amplitude (AMPL) has the highest net margin (Strategy (MSTR) -6,294.3%, Amplitude (AMPL) -26.6%).

Which stock has performed better?

Over the past year Amplitude (AMPL) returned the most: Strategy (MSTR) -48.8%, Amplitude (AMPL) +74.5%. Over five years, Strategy (MSTR) compounded fastest (Strategy (MSTR) +15.2%/yr, Amplitude (AMPL) -23.7%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Amplitude (AMPL) has been the steadiest (Strategy (MSTR) 81.1%, Amplitude (AMPL) 65.8%). Volatility measures how widely the price swings, not the risk of the business.

Do MSTR and AMPL move together?

Their daily returns over the past year have a correlation of 0.24, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, MSTR and AMPL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Amplitude (AMPL) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.